Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Endocyte Inc (NASDAQ:ECYT)

5.03
Delayed Data
As of Sep 04
 -0.12 / -2.33%
Today’s Change
4.61
Today|||52-Week Range
9.35
-20.03%
Year-to-Date
No recent news for Endocyte Inc.

Today’s Trading

Previous close5.15
Today’s open5.09
Day’s range4.98 - 5.17
Volume253,492
Average volume (3 months)314,434
Market cap$216.2M
Dividend yield--
Data as of 3:59pm ET, 09/04/2015

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)-952.31%
Earnings growth (next 5 years)--
Revenue growth (last year)+8.45%
P/E ratioNM
Price/Sales3.73
Price/Book1.05

Competitors

 Today’s
change
Today’s
% change
HSKAHeska Corp-0.43-1.30%
DRNADicerna Pharmaceutic...+0.30+2.82%
NVLSNivalis Therapeutics...+0.06+0.42%
ASMBAssembly Biosciences...+0.10+0.77%
Data as of 3:59pm ET, 09/04/2015

Financials

Next reporting dateNovember 4, 2015
EPS forecast (this quarter)-$0.27
Annual revenue (last year)$70.4M
Annual profit (last year)$5.5M
Net profit margin7.76%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
P. Ron Ellis
Chief Operating &
Financial Officer
Michael A. Sherman
Corporate headquarters
West Lafayette, Indiana

Forecasts

Partner Offers